Conmed (CNMD) Accumulated Expenses (2010 - 2026)

Conmed has reported Accumulated Expenses for 17 years, with the latest figure at $60.9 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 5.52% year-over-year to $60.9 million; the trailing twelve-month figure through Mar 2026 stood at $60.9 million (up 5.52% YoY), and the FY2025 full-year result was $82.1 million, up 25.66% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $60.9 million, down from $82.1 million in the prior quarter.
• The five-year high for Accumulated Expenses was $82.1 million in Q4 2025, with the low at $45.4 million in Q1 2022.
• Historically, Accumulated Expenses has averaged $59.8 million across 5 years, with a median of $57.7 million in 2025.
• Annual changes were most pronounced in 2022 — Accumulated Expenses retreated 9.51% — and 2023, when it gained 28.02%.
• Conmed's Accumulated Expenses stood at $54.7 million in 2022, then grew by 28.02% to $70.1 million in 2023, then declined by 6.71% to $65.4 million in 2024, then increased by 25.66% to $82.1 million in 2025, then decreased by 25.87% to $60.9 million in 2026.
• The last three Accumulated Expenses figures came in at $60.9 million (Q1 2026), $82.1 million (Q4 2025), and $76.1 million (Q3 2025), per Business Quant data.